Tilray Inc Asset Resilience Ratio
Tilray Inc asset resilience ratio. Tilray Inc (TLRY) has an Asset Resilience Ratio of 0.23% as of May 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Tilray Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Tilray Inc (2015–2026)
Asset resilience ratio of Tilray Inc from 2015 to 2026. This chart shows how Tilray Inc's Asset Resilience Ratio has changed over time. Read TLRY current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Tilray Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Tilray Inc asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.29 Million | 0.23% |
| Total Liquid Assets | $5.29 Million | 0.23% |
Asset Resilience Insights
- Limited Liquidity: Tilray Inc maintains only 0.23% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tilray Inc Industry Peers by Asset Resilience Ratio
Compare Tilray Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Tilray Inc Asset Resilience Ratio by Year (2015–2026)
Tilray Inc asset resilience ratio by year from 2015 to 2026. The table below shows the annual Asset Resilience Ratio data for Tilray Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-05-31 | 0.23% | $5.29 Million | $2.33 Billion | -1.41pp |
| 2025-05-31 | 1.64% | $47.61 Million | $2.90 Billion | +0.90pp |
| 2024-05-31 | 0.74% | $43.85 Million | $5.91 Billion | -4.76pp |
| 2023-05-31 | 5.50% | $325.83 Million | $5.92 Billion | -- |
| 2022-05-31 | 0.00% | $0.00 | $6.87 Billion | -- |
| 2020-05-31 | 0.00% | $0.00 | $868.89 Million | -- |
| 2019-05-31 | 4.62% | $30.58 Million | $661.89 Million | -61.21pp |
| 2018-05-31 | 65.83% | $34.95 Million | $53.09 Million | +64.13pp |
| 2015-05-31 | 1.69% | $156.34K | $9.23 Million | -- |
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more